| ²é¿´: 328 | »Ø¸´: 5 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß ß÷ß÷9761 µÄ 7 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
ß÷ß÷9761ͳæ (³õÈëÎÄ̳)
|
[½»Á÷]
¡¾ÇóÖú¡¿¼±ÇóһƪӢÎÄÎÄÏ×
|
||
|
±¾ÈËÖ»ÓÐÎÄÕÂÃû³Æ°¡£¬ÊµÔÚÕÒ²»µ½È«ÎÄ£¬ÄÜÕÒµ½µÄ³æ³æÃǰïæ°¡£¡Ð»Ð» Liversidge EM. Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds in: J.J. Marty (Ed.), Particles, Marcel Dekker, Orlando, 2002. |
» ²ÂÄãϲ»¶
Çó»¯Ñ§µ÷¼Á
ÒѾÓÐ5È˻ظ´
085600£¬²ÄÁÏÓ뻯¹¤321·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703 »¯Ñ§ Çóµ÷¼Á£¬Ò»Ö¾Ô¸É½¶«´óѧ 342 ·Ö
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÄÏ¿ª´óѧ0710ÉúÎïѧ359Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085600£¬×¨Òµ¿Î»¯¹¤ÔÀí£¬320·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏÓ뻯¹¤272Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
290Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085600 286·Ö ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
5Â¥2010-03-03 21:27:45
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
2Â¥2010-03-02 13:12:12
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
4Â¥2010-03-03 21:14:17
ß÷ß÷9761
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 192.3
- ºì»¨: 1
- Ìû×Ó: 36
- ÔÚÏß: 5Сʱ
- ³æºÅ: 588244
- ×¢²á: 2008-08-22
- רҵ: Ò©¼Áѧ
6Â¥2010-03-03 21:28:27














»Ø¸´´ËÂ¥